ライフサイエンスコーパス: syndrome X

1 marily components of the metabolic syndrome (syndrome X).

2 lectively known as the metabolic syndrome or syndrome X.

3 w diet produce many of the features of human syndrome X.

4 tion is scant on the childhood predictors of syndrome X.

5 scular disease associated with the metabolic syndrome X.

6 ce fat distribution and variables related to syndrome X.

7 ssure were used as measures of components of Syndrome X.

8 ripheral resistance vessels of patients with syndrome X.

9 pulation reduces the public health impact of syndrome X.

10 full cluster of abnormalities that comprise syndrome X.

11 the metabolic abnormalities that constitute syndrome X.

12 diets should be avoided in the treatment of syndrome X.

13 pertension both independently and as part of syndrome X.

14 More patients with syndrome X (17/18 [94%]) developed chest pain during ade

15 re not significantly higher in patients with syndrome X (4.8 vs. 4.0 pg/ml, p = 0.17), the vasoconstr

16 cclusion plethysmography in 10 patients with syndrome X and 10 matched control subjects.

17 (2.63 versus 2.53; P=0.60) in patients with syndrome X and controls, respectively.

18 Syndrome X and microvascular angina are a heterogenous g

19 ty is a powerful predictor of development of syndrome X and underscore the importance of weight contr

20 Eighteen patients with syndrome X (chest pain, abnormal exercise treadmill test

21 lood flow of only 20 +/- 2% in patients with syndrome X compared with 35 +/- 3% in matched control su

22 tly increased in women (but not in men) with syndrome X, compared with women with no metabolic abnorm

23 ustering of cardiovascular risk variables of Syndrome X from childhood to adulthood were examined in

24 Patients with syndrome X had normal basal and stimulated nitric oxide

25 of dyslipidemia and diabetes (components of syndrome X) have become global health epidemics.

26 ent features of insulin resistance syndrome (Syndrome X) have been identified by factor analysis in m

27 luster of metabolic abnormalities defined as syndrome X (high blood glucose, high blood pressure, low

28 Patients with X-linked hyper-IgM syndrome (X-HIGM) due to CD40 ligand (CD40L) mutations a

29 Subjects with X-linked hyper-IgM syndrome (X-HIgM) have a markedly reduced frequency of C

30 sults in X-linked hyper-immunoglobulin (Ig)M syndrome (X-HIGM), characterized by recurrent infections

31 munodeficiencies known as X-linked hyper-IgM syndrome (X-HIgM).

32 diabetes and the often-associated metabolic syndrome X (hypertriglyceridemia, low serum high density

33 insulin to the adulthood risk of developing syndrome X in a biracial (black-white) community-based l

34 applied to the clustering characteristics of Syndrome X in a biracial (Black-White) community-based p

35 of the defining features of human metabolic Syndrome X, in which hypertension associates with insuli

36 full cluster of metabolic abnormalities from syndrome X is an important risk factor for cardiovascula

37 These results suggest that Syndrome X is characterized by the linking of a metaboli

38 e occurrence of insulin resistance syndrome (syndrome X) is common in the general population.

39 rotein, alpha thalassemia/mental retardation syndrome X linked, switch/sucrose nonfermentable pathway

40 aining alpha-thalassaemia/mental retardation syndrome X-linked (ATRX) and death-domain-associated pro

41 utations in a-thalassemia/mental retardation syndrome X-linked (ATRX) and TP53.

42 e, we identify alpha-thalassemia retardation syndrome X-linked (ATRX) as a novel physical and functio

43 is the alpha-thalassaemia mental retardation syndrome X-linked (ATRX) homolog X-linked nuclear protei

44 Alpha thalassemia/mental retardation syndrome X-linked (ATRX) is a member of the SWI/SNF prot

45 roteins alpha thalassemia/mental retardation syndrome X-linked (ATRX) or death-domain associated prot

46 ponent, alpha-thalassemia/mental retardation syndrome X-linked (ATRX) protein, is predicted to be a t

47 Alpha thalassemia/mental retardation syndrome X-linked chromatin remodeler (ATRX), a DAXX (de

48 r ATRX (Alpha Thalassemia/Mental Retardation Syndrome X-Linked), which was required to maintain nucle

49 d ATRX (alpha thalassemia/mental retardation syndrome X-linked).

50 les in the pathogenesis of Smith-Lemli-Opitz syndrome, X-linked dominant chondrodysplasia punctata, a

51 increased cancer susceptibility in the human syndrome, X-linked dyskeratosis congenita (X-DC).

52 cardi-Goutieres syndrome, Hallervorden-Spatz syndrome, X-linked dystonia parkinsonism, deafness-dysto

53 In craniofrontonasal syndrome, X-linked mosaicism for ephrin-B1 expression ha

54 ed that mutations in ARX cause X-linked West syndrome, X-linked myoclonic epilepsy with spasticity an

55 istinct clinical phenotypes (Wiskott-Aldrich syndrome/X-linked thrombocytopenia; intermittent thrombo

56 These results suggest that syndrome X may be comprised of separable PPARgamma-depen

57 Patients with syndrome X may have a generalized disorder of vascular a

58 In 1987 when Reaven introduced syndrome X (metabolic syndrome, or MS), we were studying

59 line in physical functioning than either the syndrome X or primary mediator components alone.

60 Syndrome X refers to a cluster of abnormalities, associa

61 ology of chest pain in patients with cardiac syndrome X remains controversial.

62 n of the cluster of metabolic abnormalities (syndrome X) should not distract our attention from estab

63 with CMR could clarify whether patients with syndrome X show evidence of myocardial ischemia (reduced

64 Patients with syndrome X show greater sensitivity to chest pain compar

65 Syndrome X, typified by obesity, insulin resistance (IR)

66 he degree of clustering of risk variables of Syndrome X varies with age from childhood to adulthood a

67 the full cluster of metabolic abnormalities (syndrome X) was low in the population as a whole, with o